title: CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.
abstract: Extended spectrum beta-lactamase (ESBL) producing Escherichia coli has been an emerging etiologic agent in the community acquired infections. We investigated the occurrence of ESBL producing E. coli isolated from patients admitted with community acquired urinary tract infection (UTI) to the hospital of the Trakya University, Turkey during 2006. Eleven single patient isolates of E. coli harboring ESBL were identified among 30 E. coli isolated from patients admitted with symptoms corresponding to upper UTI. CTX-M type ESBLs were detected in all 11 ESBL-producers by isoelectric focusing and polymerase chain reaction screening. Sequence analysis revealed CTX-M-1 in one isolate, CTX-M-3 in three isolates and CTX-M-15 in seven isolates. ESBL-producing E. coli isolated from community acquired UTIs are widespread in the European part of Turkey.
authors.affiliation: Trakya Universitesi Tip Fakültesi, Enfeksiyon Hastaliklari ve Klinik Mikrobiyoloji AD, Edirne, Turkiye. adogancelik@yahoo.com.tr
authors.forename: Aygul Dogan
authors.initials: AD
authors.lastname: Celik
authors.forename: Zerrin
authors.initials: Z
authors.lastname: Yulugkural
authors.forename: Figen
authors.initials: F
authors.lastname: Kuloglu
authors.forename: Cafer
authors.initials: C
authors.lastname: Eroglu
authors.forename: Sinem
authors.initials: S
authors.lastname: Torol
authors.forename: Haluk
authors.initials: H
authors.lastname: Vahaboğlu
authors.forename: Filiz
authors.initials: F
authors.lastname: Akata
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D017714:Community-Acquired Infections / Q000382:microbiology*; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000382:microbiology*; D029968:Escherichia coli Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000302:isolation & purification; D005838:Genotype; D006785:Hospitals, University; D006801:Humans; D007525:Isoelectric Focusing; D008826:Microbial Sensitivity Tests; D016133:Polymerase Chain Reaction; D017422:Sequence Analysis, DNA; D014421:Turkey; D014552:Urinary Tract Infections / Q000382:microbiology*; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000145:classification / Q000235:genetics / Q000302:isolation & purification; D047090:beta-Lactams / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D029968:Escherichia coli Proteins; D047090:beta-Lactams; D001618:beta-Lactamases